Fagron N.V.

Fagron N.V.

ARSUF

$27.50

Updated: 24/09/2026, 09:07:18

Market Cap
$2.02B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
BE
Stock valuation chart
One-year closing share-price history for ARSUF
Company Profile

Fagron N.V. is a specialized pharmaceutical compounding firm focused on delivering tailored medicinal solutions. The company caters to a diverse range of clients, including hospitals, pharmacies, clinics, and individual patients. Beyond providing direct services, Fagron N.V. actively drives innovation by developing cutting-edge concepts, delivery methods, and specific formulations for pharmaceutical compounding. Its extensive product line includes essential raw materials, specialized tools and equipment, semi-finished goods, various drug vehicles, and both sterile and non-sterile custom-prepared medications. Furthermore, the company supports professional development through the Fagron Academy, offering comprehensive education and training programs for medical prescribers and pharmacists. With a significant global presence, Fagron N.V. operates across Latin America, North America, Europe, the Middle East, and Africa. Founded in 1990 and headquartered in Nazareth, Belgium, the company underwent a name change in January 2015, rebranding from its former identity, Arseus N.V., to Fagron N.V.

USD
OTC
CEO: Rafael Padilla
Employees: 4,134
https://www.fagron.com
Asset Summaries
Latest generated summaries for ARSUF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ARSUF.
Share price
$27.50
Market cap
$2.02B
Exchange
OTC
Currency
USD
CEO
Rafael Padilla
Employees
4,134
IPO date
21/02/2017
Beta
0.386
Last dividend
$0.00
Day range
$27.50 – $27.50
52-week range
$23.50 – $27.90
1-day performance
0.00%
1-year performance
17.02%
Current drawdown (1Y)
-1.43%
CIK
N/A
CUSIP
N/A
ISIN
BE0003874915
Created
07/12/2025, 02:09:20
Last update
24/09/2026, 09:07:18

Track Fagron N.V. with an AI analyst

See which prediction-market events move ARSUF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.